Skip to main content
. 2019 Jul 9;10(43):4479–4491. doi: 10.18632/oncotarget.27065

Table 1. Primers used in this study.

Gene primers Sequences Length
β-actin forward AGAGGGAAATCGTGCGTGAC 20
β-actin reverse CAATAGTGATGACCTGGCCGT 21
IL-12 forward CTGTGCCTTGGTAGCATCTATG 22
IL-12 reverse GCAGAGTCTCGCCATTATGATTC 23
IL-21 forward GGACCCTTGTCTGTCTGGTAG 21
IL-21 reverse TGTGGAGCTGATAGAAGTTCAGG 23
IFNγ forward TCAAGTGGCATAGATGTGGAAGAA 24
IFNγ reverse TGGCTCTGCAGGATTTTCATG 21
CXCL10 forward CCAAGTGCTGCCGTCATTTTC 21
CXCL10 reverse GGCTCGCAGGGATGATTTCAA 21
IL-10 forward GCTCTTACTGACTGGCATGAG 21
IL-10 reverse CGCAGCTCTAGGAGCATGTG 20
CCL5 forward CAGCAGCAAGTGCTCCAATCTT 22
CCL5 reverse TTCTTGAACCCACTTCTTCTCTGG 24